Drug intelligence / Profile preview

Sangqi Qingxuan

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Sangqi Qingxuan is a traditional Chinese medicine (TCM) multi-herbal formula used primarily for the prevention and treatment of hypertension and hypertensive vascular remodeling. It contains multiple bioactive components that act on various molecular targets associated with vascular health. Mechanistic studies indicate that its antihypertensive and vasoprotective effects are mediated through modulation of the Wnt/β-catenin signaling pathway as well as inhibition of the ERK/MAPK signaling pathway. These actions help protect arterial vascular endothelial cells (AVECs), reduce blood pressure, inhibit phenotypic transformation of vascular smooth muscle cells, and improve overall vascular function in hypertension models[2][3]. The formula is typically administered as a liquid or decoction.

Brand names
Sangqi Qingxuan
Other names
Sangqi Qingxuan formulaSangqi Qingxuan LiquidSQQX
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TP53 (Cellular Tumor Antigen p53 R175H)

Beyond the preview

Go deeper on Sangqi Qingxuan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sangqi Qingxuan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call